Search results
Results from the WOW.Com Content Network
Geron, based in Foster City, California, was founded by gerontologist Mary C. West and Michael D. West, now CEO of AgeX Therapeutics. [2] [3] They secured initial venture capital investments in the company from Kleiner Perkins Caufield & Byers and Venrock. [4] The company was incorporated in 1990 and began doing business in 1992.
March 12, 2024 at 11:58 AM. By Christy Santhosh and Pratik Jain. (Reuters) -The U.S. Food and Drug Administration's staff reviewers said on Tuesday they were unclear if Geron's blood disorder drug ...
Today, fool.com health-care analysts David Williamson and Brenton Flynn look at the biggest news across their sector. One big headline is Geron's performance in August, when the company had weak ...
Gerontology (/ ˌ dʒ ɛr ən ˈ t ɒ l ə dʒ i / JERR-ən-TOL-ə-jee) is the study of the social, cultural, psychological, cognitive, and biological aspects of aging.The word was coined by Ilya Ilyich Mechnikov in 1903, from the Greek γέρων (gérōn), meaning "old man", and -λογία (), meaning "study of".
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company Geron (NAS: GERN) has received a ...
WARF and Geron did not charge academics to study human stem cells but did charge commercial users. In 2001 WARF came under public pressure to widen access to human stem-cell technology. WARF sued GERON Corp. to recover some of the previously sold rights. The two sides agreed that GERON Corp. would keep the rights to only three cell types.
Geron has had a wild ride this year, bouncing between a 52-week low of $0.98 in April all the way to a high of $7.79 earlier this month. Investors who held on to shares through that volatility ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Help; Learn to edit; Community portal; Recent changes; Upload file